Richard Cerione, PhD

Dr. Richard Cerione's research focuses on the molecular basis of GPCR- and growth factor-stimulated cellular responses and how aberrant signaling can lead to diseases. His current work explores how Rho GTPases signal to the metabolic machinery of cancer cells and the roles of extracellular shed vesicles in various biological processes.

Dr. Cerione is the Principal Investigator of MacCHESS (Macromolecular Diffraction at the Cornell High Energy Synchrotron Source). He has authored over 300 publications and received numerous awards and honors. His laboratory has been funded by the National Institutes of Health, the American Cancer Society, and the Department of Defense program for breast cancer. He has served on various editorial boards, review panels, and NIH study sections.

Dr. Cerione earned his undergraduate degree in Biochemistry from Rutgers College and a PhD in Biochemistry from Rutgers University. He trained as an NIH postdoctoral fellow in the Department of Chemistry at Cornell University with Gordon Hammes and later served as a Senior Research Associate in the Department of Medicine at Duke University Medical Center with Robert Lefkowitz. In 1985, he joined the faculty of Cornell University as an Assistant Professor in the Department of Pharmacology and now holds joint appointments in the Department of Molecular Medicine and the Department of Chemistry and Chemical Biology.